MedPath

Examination of effectiveness of combination therapy of periodontal tissue regeneration drug, Regroth, and carbonate apatite, Cytrans Granules, for periodontal tissue regenaratio

Not Applicable
Recruiting
Conditions
Periodontal Disease
Registration Number
JPRN-UMIN000037940
Lead Sponsor
Tokushima University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with severe systemic disease Patients who may be pregnant or pregnant Patients with mental illness Patients with hypersensitivity to "Regroth" or "Cytrans Granules" Patients with malignant tumor in oral cavity or patients with its history Case of predicted not to able to complete closure of wound surface when filling with Cytrans Granules Tooth for severe periodontal disease and tooth extraction adapted tooth

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath